U.S. Food Stock News

Recent analyst reports on Marex Group (MRX) highlight increased optimism around the company’s earnings outlook. Several firms have revised their forecasts higher and reiterated positive ratings, drawing fresh attention to the stock. See our latest analysis for Marex Group. The recent earnings optimism has coincided with a 32.28% 90 day share price return and a 21.80% total shareholder return over the past year, suggesting momentum has been building around Marex Group, which had a last close...

Earlier this week, Truist Financial Corporation announced it had hired former JPMorgan Chase executive Mark Cuccinello as Head of Structured Credit, overseeing asset-based lending, working capital solutions, and equipment finance within its Wholesale Banking platform. This leadership move, alongside analysts’ more optimistic earnings expectations, highlights Truist’s focus on strengthening fee-rich structured credit capabilities and aligning its lending franchises more tightly with corporate...

In recent weeks, Brinker International’s Chili’s brand extended its multi-year NASCAR sponsorship with Spire Motorsports, while analysts and commentators such as Jim Cramer and Evercore’s David Palmer highlighted the company’s management execution, pricing discipline, and value proposition for middle-income guests. At the same time, Brinker's upcoming January 28, 2026 earnings call and upward earnings estimate revisions have focused attention on how its operational decisions and marketing...

In recent days, eBay released its first climate transition plan, setting a net-zero greenhouse gas emissions goal by 2045 and outlining substantial cuts to operational and supply-chain emissions, including freight and shipping. A distinctive aspect of the plan is eBay’s intent to lean on its recommerce marketplace and circular fashion initiatives to curb logistics emissions while supporting more sustainable consumer behaviour. We’ll now explore how eBay’s new net-zero roadmap, particularly...

Recent comments from Merit Medical Systems (MMSI) leadership put mergers and acquisitions firmly in focus. The company highlighted disciplined deal making, a growing cash war chest, and an intent to target specific gaps in its portfolio. See our latest analysis for Merit Medical Systems. The recent leadership shift, fresh revenue guidance and clear M&A focus come against a mixed backdrop, with a 1 year total shareholder return of 20% decline contrasting with 17.2% and 42.38% total shareholder...

McCormick & Company, Incorporated recently announced a two-year collaboration with Paris Hilton and her media company 11:11 Media, centered on a new advertising campaign that links its spices, seasonings, and extracts with memorable food, film, and TV moments. The partnership is intended to help McCormick evolve its brand for younger consumers while honoring its heritage, positioning the company as a “house of flavor” that stays culturally relevant to the next generation of home cooks. We’ll...

In recent days, several research firms reaffirmed positive ratings on Kirby Corporation and expressed increased confidence in its operational and market positioning. This cluster of upbeat analyst views adds fresh external validation to Kirby’s existing investment case around marine transport capacity and industrial demand exposure. We’ll now examine how this growing analyst confidence could reshape Kirby’s investment narrative and investors’ assessment of its long-term prospects. AI is...

In late 2025, Schneider National reported US$60,000 in Q4 lobbying focused on trucking policy issues and marked the first anniversary of its Cowan Systems acquisition, which has expanded its Dedicated fleet and regional reach while supporting revenue tied to more contracted freight. At the same time, analysts have maintained generally positive views on Schneider National, highlighting the Cowan integration and a shift toward more stable, dedicated and intermodal revenue even as insiders have...

Dyne Therapeutics (DYN) is back in focus after its appearance at the 44th Annual J.P. Morgan Healthcare Conference, where CEO John G. Cox outlined progress in programs targeting myotonic dystrophy type 1 and Duchenne muscular dystrophy. See our latest analysis for Dyne Therapeutics. Despite recent enthusiasm around Dyne’s neuromuscular programs and conference visibility, the 30 day share price return of 11.61% and year to date share price return of 9.70% contrast with a 1 year total...

Array Technologies (ARRY) has been in focus after a sharp business recovery, marked by strong revenue growth, sizeable bookings and the APA acquisition. Together, these developments have shifted how many investors view the stock. See our latest analysis for Array Technologies. Those operational headlines have been reflected in the trading pattern, with a 14.68% 30 day share price return and a 9.83% 90 day gain, even though the year to date share price return is slightly negative and the 3...

Why STAAR Surgical Is Back in Focus After the Failed Alcon Deal STAAR Surgical (STAA) is back on investors’ radar after shareholders rejected its cash sale to Alcon and the company confirmed it will continue as an independent, publicly traded business. That decision has quickly been followed by a broad refresh of the boardroom, new committee structures and an active search for a new chief executive, all with heavy involvement from STAAR’s largest shareholders. See our latest analysis for...

AZZ Inc. recently reported third-quarter fiscal 2026 results showing higher sales of US$425.75 million and net income of US$41.08 million year on year, while also narrowing full-year revenue guidance to US$1.625 billion–US$1.7 billion, authorizing a US$0.20 per share dividend, and completing a share buyback of 1,134,067 shares since 2020. Management highlighted strong momentum in Metal Coatings, an active pipeline of small bolt-on acquisitions, and ongoing capital returns via dividends and...

Why Worthington Enterprises is on investors’ radar today Worthington Enterprises (WOR) has been drawing attention after a mixed stretch in recent trading, with the share price drifting lower over the past month and past 3 months while longer term returns remain positive. See our latest analysis for Worthington Enterprises. At around US$53.43, the share price has eased in the short term, with a 1 day share price return of a 2.0% decline and a 90 day share price return of a 5.5% decline, while...

Wells Fargo’s Ike Boruchow recently upgraded Burlington Stores (BURL) to a buy rating, a move that has sharpened investor focus on how the off price retailer’s fundamentals compare with this renewed optimism. See our latest analysis for Burlington Stores. The recent upgrade lands after a strong short term run, with a 30 day share price return of 14.22% and a 90 day share price return of 11.57%, while the latest close sits at US$306.31. At the same time, the 1 year total shareholder return of...

Why ERAS-0015 trial data is moving Erasca (ERAS) into focus Erasca (ERAS) has drawn fresh attention after early data from its AURORAS-1 Phase 1 trial for ERAS-0015, presented at the JP Morgan Healthcare Conference, showed partial responses and a clean safety profile in RAS-mutated tumors. The company reported two confirmed partial responses and one unconfirmed partial response at a low 8 mg once daily dose, with no dose-limiting toxicities and largely low grade side effects across evaluated...

Recent performance snapshot for RadNet With no single headline event driving RadNet (RDNT) today, the stock’s recent performance offers useful context, including a 1 day return of about a 3% decline and a past 3 months return near an 8% decline. See our latest analysis for RadNet. At the current share price of US$70.99, RadNet’s recent 7 day and 90 day share price declines sit against a much stronger backdrop, with 1 year total shareholder return of 18.59% and very large 3 and 5 year total...

Why VeriSign (VRSN) Is On Investors’ Radar Today VeriSign (VRSN) is back in focus after recent share price moves, with the stock showing mixed short and longer term returns while sitting on annual revenue of US$1.63b and net income of US$811.0m. See our latest analysis for VeriSign. At a share price of US$249.47, VeriSign has logged a 2.61% 1 month share price return, while its 1 year total shareholder return of 19.99% points to momentum that has held up even as the 3 month share price return...

Event context and why it matters for PureCycle PureCycle Technologies (PCT) is in focus after partnering with Churchill Container and 4ocean to supply reusable Run It Back souvenir cups made with its recycled resin at the College Football Playoff National Championship. The program ties every 20 cups sold to the removal of one pound of ocean trash, giving PureCycle a high profile platform for its recycling technology and putting a clear environmental metric in front of fans and investors. See...

Multiple large research firms have recently reaffirmed or upgraded their views on Lowe's Companies (LOW), citing the retailer's focus on operational efficiency, potential for margin improvement, growth in professional customers, and continued investment in digital capabilities. See our latest analysis for Lowe's Companies. Lowe's share price has been gaining momentum, with a 30 day share price return of 11.93% and a year to date share price return of 12.42%. The 5 year total shareholder...

M&T Bank (MTB) closed out FY 2025 with fourth quarter revenue of US$2.4 billion and basic EPS of US$4.71, alongside net income of US$718 million, framing a year where the trailing 12 month tally reached US$9.2 billion of revenue and US$17.10 in EPS. Over the past few quarters, revenue has moved from US$2.2 billion in Q4 2024 to US$2.4 billion in Q4 2025, while quarterly EPS increased from US$3.88 to US$4.71, supported by higher net income. This sets up a results season in which investors are...

In early January 2026, Rapport Therapeutics announced past and planned advances across its clinical pipeline, including preparing a Phase 3 program for RAP-219 in focal onset seizures, expanding into primary generalized tonic-clonic seizures, and resuming its Phase 2 diabetic peripheral neuropathic pain trial after the FDA lifted a clinical hold. A key insight is that Rapport is concentrating resources on programs it believes can meaningfully address unmet neurological needs while supporting...

Peabody Energy (BTU) has drawn fresh attention after President and CEO Jim Grech was appointed Chair of the National Coal Council, an advisory body to the U.S. Secretary of Energy on coal policy. See our latest analysis for Peabody Energy. The leadership spotlight from Jim Grech’s new policy role comes alongside strong recent momentum, with a 27.58% 1 month share price return and a 91.52% 1 year total shareholder return at a latest share price of $36.36. If Peabody’s recent move has you...

If you are wondering whether SS&C Technologies Holdings at around US$85.78 is offering fair value or a potential mispricing, you are in the right place. The share price has been relatively steady in the short term, with a 1.4% decline over the last 7 days and a 1.1% decline over the last 30 days, while the 1 year return sits at 10.6% and the 3 year return at 59.0%. These moves sit alongside ongoing interest in SS&C as a major software and services provider to financial institutions, with...

Executive Changes Put Dow (DOW) Leadership in Focus Dow (DOW) has drawn fresh attention after announcing upcoming leadership changes in its technology and board ranks. These developments arrive as investors reassess exposure to large US materials and plastics producers. See our latest analysis for Dow. At a share price of US$27.57, Dow’s recent 30 day share price return of 19.51% and 90 day share price return of 25.95% sit in sharp contrast to its 1 year total shareholder return of 27.80% and...